169 related articles for article (PubMed ID: 20423715)
1. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
[TBL] [Abstract][Full Text] [Related]
2. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
5. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
[TBL] [Abstract][Full Text] [Related]
6. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.
Mizukami S; Watanabe Y; Nakajima K; Hasegawa-Baba Y; Jin M; Yoshida T; Shibutani M
Toxicol Sci; 2017 Sep; 159(1):211-223. PubMed ID: 28903497
[TBL] [Abstract][Full Text] [Related]
8. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
[TBL] [Abstract][Full Text] [Related]
9. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
[TBL] [Abstract][Full Text] [Related]
10. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
[TBL] [Abstract][Full Text] [Related]
12. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
[TBL] [Abstract][Full Text] [Related]
14. Tumor promotion by copper-overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcinogenesis model.
Mizukami S; Ichimura R; Kemmochi S; Wang L; Taniai E; Mitsumori K; Shibutani M
Chem Biol Interact; 2010 May; 185(3):189-201. PubMed ID: 20302851
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.
Mizukami S; Watanabe Y; Saegusa Y; Nakajima K; Ito Y; Masubuchi Y; Yoshida T; Shibutani M
Toxicol Appl Pharmacol; 2017 Nov; 334():207-216. PubMed ID: 28899750
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
18. Smad phospho-isoforms direct context-dependent TGF-β signaling.
Matsuzaki K
Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
[TBL] [Abstract][Full Text] [Related]
19. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
